Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "Osteoporosis-pseudoglioma syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Condition: Osteoporosis Pseudoglioma Syndrome
Intervention: Biological: Human recombinant growth hormone
2 Active, not recruiting Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
Condition: Osteoporosis Pseudoglioma
Intervention: Drug: Lithium

Indicates status has not been verified in more than two years